echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > China National Medical Products Administration Approves Baizean(R) for Second-Line or Third-Line Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    China National Medical Products Administration Approves Baizean(R) for Second-Line or Third-Line Treatment of Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer

    • Last Update: 2022-01-26
    • Source: Internet
    • Author: User
    Tags

    epinephrine drug

    chief people officer
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com